Lowey Dannenberg, P.C. is Investigating DaVita Inc. (NYSE: DVA) for Potential Violations of the Federal Securities Laws
Law firm Lowey Dannenberg is investigating DaVita Inc. for potential securities law violations following the HHS announcement of a coordinated strategy to revitalize American kidney care by introducing competition measures and penalizing market dominance in the dialysis industry. DaVita's stock fell 6.23% ($11.65 per share) on October 20, 2026, following the announcement, as investors question whether the company adequately disclosed regulatory and competitive risks.